Phase I/II Trial of Temozolomide (TMZ), Motexafin Gadolinium (MGd), and 60 Gy Fractionated Radiation (RT) for Newly Diagnosed Supratentorial Glioblastoma Multiforme (GBM): Final Re...

por Brachman, David G., Pugh, Stephanie L, Ashby, Lynn S., Thomas, Theresa A., Dunbar, Erin M., Narayan, Samir, Robins, H. Ian, Bovi, Joseph A., Rockhill, Jason K., Won, Minhee, Curran, Walter P.
Publicado en Int J Radiat Oncol Biol Phys (2015)